Submission Details
| 510(k) Number | K141375 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 27, 2014 |
| Decision Date | February 13, 2015 |
| Days to Decision | 262 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K141375 is an FDA 510(k) clearance for the ELIA M2; IMMUNOASSAY, POSITIVE CONTROL 100, POSITIVE CONTROL 250, a Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control (Class II — Special Controls, product code DBM), submitted by Phadia US, Inc. (Freiburg Im Breisgau, DE). The FDA issued a Cleared decision on February 13, 2015, 262 days after receiving the submission on May 27, 2014. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5090.
| 510(k) Number | K141375 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 27, 2014 |
| Decision Date | February 13, 2015 |
| Days to Decision | 262 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | DBM — Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5090 |